These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15292288

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Congenital adrenal hyperplasia and violation of newborn screening procedures.
    Odajima H, Hosono S, Kayama K, Yoshikawa K, Takahashi S.
    Pediatr Int; 2017 Oct; 59(10):1107-1108. PubMed ID: 28960615
    [No Abstract] [Full Text] [Related]

  • 23. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.
    Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
    [Abstract] [Full Text] [Related]

  • 24. The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives.
    de Hora M, Heather N, Webster D, Albert B, Hofman P.
    Front Endocrinol (Lausanne); 2023 Feb; 14():1226284. PubMed ID: 37850096
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Monitoring of congenital adrenal hyperplasia by microbore HPLC-electrospray ionization tandem mass spectrometry of dried blood spots.
    Lai CC, Tsai CH, Tsai FJ, Wu JY, Lin WD, Lee CC.
    Clin Chem; 2002 Feb; 48(2):354-6. PubMed ID: 11805018
    [No Abstract] [Full Text] [Related]

  • 27. Newborn Screening and Diagnosis of Infants with Congenital Adrenal Hyperplasia.
    Vats P, Dabas A, Jain V, Seth A, Yadav S, Kabra M, Gupta N, Singh P, Sharma R, Kumar R, Polipalli SK, Batra P, Thelma BK, Kapoor S.
    Indian Pediatr; 2020 Jan 15; 57(1):49-55. PubMed ID: 31937698
    [Abstract] [Full Text] [Related]

  • 28. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS, Allen DB, Hoffman GL.
    J Pediatr; 2005 Oct 15; 147(4):493-8. PubMed ID: 16227036
    [Abstract] [Full Text] [Related]

  • 29. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia.
    Gleeson HK, Wiley V, Wilcken B, Elliott E, Cowell C, Thonsett M, Byrne G, Ambler G.
    J Paediatr Child Health; 2008 Oct 15; 44(10):554-9. PubMed ID: 19012627
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
    González EC, Carvajal F, Frómeta A, Arteaga AL, Castells EM, Espinosa T, Coto R, Pérez PL, Tejeda Y, Del Río L, Segura MT, Almenares P, Robaina R, Fernández JL.
    Clin Chim Acta; 2013 Jun 05; 421():73-8. PubMed ID: 23481450
    [Abstract] [Full Text] [Related]

  • 32. Comparison of different preparation techniques of dried blood spot quality controls in newborn screening for congenital adrenal hyperplasia.
    Grecsó N, Zádori A, Baráth Á, Galla Z, Rácz G, Bereczki C, Monostori P.
    PLoS One; 2021 Jun 05; 16(5):e0252091. PubMed ID: 34015037
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Changing perspectives in screening for congenital hypothyroidism and congenital adrenal hyperplasia.
    Mitchell ML, Hsu HW, Sahai I.
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb 05; 21(1):39-44. PubMed ID: 24275619
    [Abstract] [Full Text] [Related]

  • 36. The physical, emotional, and financial trauma incurred by infants and their families when an existing condition is not detected by newborn screening.
    Leight KR.
    Pediatrics; 2006 Oct 05; 118(4):1801-2; author reply 1802. PubMed ID: 17015582
    [No Abstract] [Full Text] [Related]

  • 37. Neonatal screening for congenital adrenal hyperplasia in Japan.
    Tajima T, Fujikura K, Fukushi M, Hotsubo T, Mitsuhashi Y.
    Pediatr Endocrinol Rev; 2012 Oct 05; 10 Suppl 1():72-8. PubMed ID: 23330248
    [Abstract] [Full Text] [Related]

  • 38. Recent progress in neonatal mass screening for congenital hypothyroidism and adrenal hyperplasia using enzyme immunoassays.
    Tsuji A, Maeda M, Arakawa H.
    Adv Clin Chem; 1990 Oct 05; 28():109-43. PubMed ID: 2077875
    [No Abstract] [Full Text] [Related]

  • 39. Influence of spironolactone on neonatal screening for congenital adrenal hyperplasia.
    Terai I, Yamano K, Ichihara N, Arai J, Kobayashi K.
    Arch Dis Child Fetal Neonatal Ed; 1999 Nov 05; 81(3):F179-83. PubMed ID: 10525019
    [Abstract] [Full Text] [Related]

  • 40. [Do we need congenital adrenal hyperplasia screening for premature infants?].
    Huet F, Godefroy A, Cheillan D, Somma C, Roussey M.
    Arch Pediatr; 2014 Feb 05; 21(2):233-6. PubMed ID: 24361036
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.